These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24590453)

  • 1. The population impact of familial cancer, a major cause of cancer.
    Frank C; Fallah M; Ji J; Sundquist J; Hemminki K
    Int J Cancer; 2014 Apr; 134(8):1899-906. PubMed ID: 24590453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C; Czene K
    Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attributable risks of familial cancer from the Family-Cancer Database.
    Hemminki K; Czene K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1638-44. PubMed ID: 12496055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
    Hemminki K; Czene K
    Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of shared environmental factors to familial aggregation of common cancers: an adoption study in Sweden.
    Sundquist K; Sundquist J; Ji J
    Eur J Cancer Prev; 2015 Mar; 24(2):162-4. PubMed ID: 25415834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Frank C; Sundquist J; Yu H; Hemminki A; Hemminki K
    Int J Cancer; 2017 Apr; 140(7):1510-1516. PubMed ID: 28006863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
    Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: a nationwide family study.
    Zöller B; Li X; Sundquist J; Sundquist K
    Eur J Cancer; 2014 Sep; 50(13):2319-27. PubMed ID: 24953336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
    Hemminki K; Li X
    Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial risks in in situ cancers from the Family-Cancer Database.
    Hemminki K; Vaittinen P
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):865-8. PubMed ID: 9796630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.
    Dong C; Hemminki K
    Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
    Mousavi SM; Fallah M; Sundquist K; Hemminki K
    Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
    Brown KF; Rumgay H; Dunlop C; Ryan M; Quartly F; Cox A; Deas A; Elliss-Brookes L; Gavin A; Hounsome L; Huws D; Ormiston-Smith N; Shelton J; White C; Parkin DM
    Br J Cancer; 2018 Apr; 118(8):1130-1141. PubMed ID: 29567982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
    Brandt A; Sundquist J; Hemminki K
    Br J Dermatol; 2011 Aug; 165(2):342-8. PubMed ID: 21457213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
    Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
    Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.